Skip to main content
. 2020 May 27;12(6):485. doi: 10.3390/pharmaceutics12060485

Table 2.

Experimental runs, variables levels, and observed responses of FLB niosomes prepared according to the Box–Behnken design.

Experimental Run # Independent Variables Vesicle Size
(nm) ± SD #
Entrapment Efficiency (%) ± SD &
Span® 85 conc. (µM) Hydration Time (min.) Hydrating Buffer pH
F1 1.00 37.50 3.00 272.4 ± 8.56 51.7 ± 1.23
F2 3.50 15.00 3.00 114.3 ± 2.35 60.3 ± 1.98
F3 6.00 60.00 6.00 46.2 ± 2.14 94.3 ± 1.56
F4 3.50 37.50 6.00 118.4 ± 5.28 68.8 ± 0.98
F5 1.00 15.00 6.00 191.6 ± 3.56 53.7 ± 0.78
F6 3.50 37.50 6.00 119.4 ± 1.47 69.9 ± 3.42
F7 3.50 15.00 9.00 112.4 ± 1.89 71.5 ± 2.67
F8 6.00 37.50 3.00 56.7 ± 2.19 82.3 ± 3.99
F9 3.50 37.50 6.00 102.8 ± 1.59 68.6 ± 3.12
F10 3.50 60.00 9.00 110.4 ± 3.36 75.3 ± 2.59
F11 3.50 37.50 6.00 117.9 ± 1.98 67.7 ± 2.11
F12 6.00 37.50 9.00 107.6 ± 2.11 98.5 ± 4.67
F13 3.50 37.50 6.00 120.8 ± 0.98 69.5 ± 2.54
F14 6.00 15.00 6.00 61.3 ± 4.45 86.6 ± 4.17
F15 3.50 60.00 3.00 115.6 ± 3.65 65.7 ± 2.97
F16 1.00 37.50 9.00 205.6 ± 5.43 59.5 ± 3.32
F17 1.00 60.00 6.00 196.2 ± 6.43 55.6 ± 2.47

Abbreviations: FLB, Flibanserin; SD, standard deviation; Results are presented as mean ± SD, # n = 5, & n = 3.